Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis

This study has been completed.
Peninsula Pharmaceuticals, Inc.
Information provided by:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Identifier:
First received: September 13, 2005
Last updated: June 8, 2011
Last verified: April 2010